insights_auto
Why is ORX up 2,67%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,08 SEK
arrow_upward
+2,67%(+0,028) 1D
10 қар., 17:29:51 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,06 SEK
High
1,15 SEK
Low
0,91 SEK
Mkt. cap
377,25 млн
Avg. vol.
582,45 м.
Volume
956,12 м.
P/E ratio
0,05
52-wk high
22,55 SEK
52-wk low
0,81 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,06 SEK
High
1,15 SEK
Low
0,91 SEK
Mkt. cap
377,25 млн
Avg. vol.
582,45 м.
Volume
956,12 м.
P/E ratio
0,05
52-wk high
22,55 SEK
52-wk low
0,81 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Stocktwits
·
25 минут бұрын
Can The S&P 500 Keep Rising In 2027? UBS Bets On 8,900, But BofA Warns Of Crowded Trades
The Motley Fool
·
31 минут бұрын
S&P 500 Sell-Off: 1 Investing Step to Take Right Now, and 1 Risky Move to Avoid
Eurasia Business News
·
2 сағат бұрын
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Fall on November 10, 2026; Oil and Gold Retreat
Traders Union
·
1 сағат бұрын
Correlations rose sharply between ex-AI basket and S&P 500 last week, Jurrien Timmer notes
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com